SINEMET CR 50mg/200mg Prolonged-release Tablets
- Name:
SINEMET CR 50mg/200mg Prolonged-release Tablets
- Company:
MSD Ireland (Human Health) Limited
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may be renewed (B)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 15/07/19

Click on this link to Download PDF directly
MSD Ireland (Human Health) Limited

Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 15 July 2019 PIL
Reasons for updating
- Change to section 4 - how to report a side effect
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
- Change to other sources of information section
Updated on 28 August 2018 PIL
Reasons for updating
- New PIL for new product
Updated on 28 August 2018 SPC
Reasons for updating
- New SPC for medicines.ie
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 14 November 2017 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 14 November 2017 SPC
Reasons for updating
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 10 - Date of revision of the text
- Change to section 4.4 - Special warnings and precautions for use
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Update to sections 4.4 & 4.8 in line with the PRAC recommendation on carbidopa / levodopa regarding Dopamine dysregulation syndrome
Update to section 5.1 to insert the ATC code & pharmacotherapeutic group
Updated on 14 November 2017 PIL
Reasons for updating
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 10 - Date of revision of the text
- Change to section 4.4 - Special warnings and precautions for use
Free text change information supplied by the pharmaceutical company
Update to sections 4.4 & 4.8 in line with the PRAC recommendation on carbidopa / levodopa regarding Dopamine dysregulation syndrome
Update to section 5.1 to insert the ATC code & pharmacotherapeutic group
Updated on 15 January 2016 SPC
Reasons for updating
- Change to section 3 - Pharmaceutical form
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Which SPC sections have changed: Sections 3, 10
Detailed SPC change information: Amendment to tablet description in section 3 (scoreline and “521” are now on opposite sides)
Updated on 15 January 2016 PIL
Reasons for updating
- Change to section 3 - Pharmaceutical form
- Change to section 10 - Date of revision of the text
Free text change information supplied by the pharmaceutical company
Which SPC sections have changed: Sections 3, 10
Detailed SPC change information: Amendment to tablet description in section 3 (scoreline and “521” are now on opposite sides)
Updated on 21 August 2014 SPC
Reasons for updating
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 21 August 2014 PIL
Reasons for updating
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Free text change information supplied by the pharmaceutical company
Updated on 17 June 2013 PIL
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 10 - Date of revision of the text
Free text change information supplied by the pharmaceutical company
MA Holder address change - Sections 7, 10
Updated on 17 June 2013 SPC
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
MA Holder address change - Sections 7, 10
Updated on 19 February 2013 SPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 19 February 2013 PIL
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Free text change information supplied by the pharmaceutical company
Updated on 16 October 2009 PIL
Reasons for updating
- Change to section 4.9 - Overdose
- Correction of spelling/typing errors
Free text change information supplied by the pharmaceutical company
Post BSR
(correction)
Typo correction Section 4.9
Updated on 16 October 2009 SPC
Reasons for updating
- Change to section 4.9 - Overdose
- Correction of spelling/typing errors
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Post BSR
(correction)
Typo correction Section 4.9
Updated on 9 October 2009 SPC
Reasons for updating
- Change to section 1 - Name of medicinal product
- Change to section 6.4 - Special precautions for storage
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
- Section 1: Product name
- Section 6.4: Storage conditions
- Section 10: Date of revision
Updated on 9 October 2009 PIL
Reasons for updating
- Change to section 1 - Name of medicinal product
- Change to section 6.4 - Special precautions for storage
- Change to section 10 - Date of revision of the text
Free text change information supplied by the pharmaceutical company
- Section 1: Product name
- Section 6.4: Storage conditions
- Section 10: Date of revision
Updated on 24 August 2009 SPC
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - MA number
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
- Section 7: Change of MAH holder
- Section 8: Change of PA number
- Section 10: July 2009
Updated on 24 August 2009 PIL
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - MA number
- Change to section 10 - Date of revision of the text
Free text change information supplied by the pharmaceutical company
- Section 7: Change of MAH holder
- Section 8: Change of PA number
- Section 10: July 2009
Updated on 24 July 2008 SPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
The change relates to update section 4.4 to include warning in relation to melanoma.
Updated on 24 July 2008 PIL
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
Free text change information supplied by the pharmaceutical company
The change relates to update section 4.4 to include warning in relation to melanoma.
Updated on 28 August 2007 SPC
Reasons for updating
- New SPC for medicines.ie
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 28 August 2007 PIL
Reasons for updating
- New SPC for medicines.ie